Delaware sees first Cyclosporiasis case in ongoing multistate outbreak | The Latest from WDEL News
The Delaware Department of Health and Social Services (DHS) has confirmed the state’s first case of Cyclosporiasis as…
Surgeons Warn: Don’t Ignore These Colorectal Cancer Symptoms, No Matter Your Age
Colon cancer, also known as colorectal cancer when it involves the rectum, develops in the large intestine and…
Scientists Uncover Cause of Inflammatory Bowel Disease Solving Decades-Old Mystery
Researchers have identified a distinct subgroup of inflammatory bowel disease (IBD) patients whose condition appears to be driven…
Norfolk nonprofit hospital paid a doctor nearly $5 million | News
Nebraska’s state auditor calls it inexplicable. A former health insurance CEO suggests it’s excessive. A veteran doctor says…
Scientists Warn: America’s Most Popular Cooking Oil May Be Harming Your Intestines
Soybean oil is one of the most widely used oils in the American diet, though many people may…
New Study Reveals How Vitamin D Could Calm Gut Inflammation
Scientists have uncovered evidence that vitamin D supplementation could alter immune activity in patients with Crohn’s disease and…
Scientists Flip Immune System “Switch,” Uncover Surprising Path To Stop Gut Inflammation
Inflammatory bowel disease (IBD) is a chronic condition involving abnormal immune-driven inflammation of the gastrointestinal tract, most commonly…
Renown Children’s Hospital pediatricians advise on GI illnesses amid outbreaks at five WCSD schools | Local News
MAY 1 UPDATE: Renown Children’s Hospital pediatric experts are alerting parents and caregivers to an increase in gastrointestinal illness among…
Breakthrough Bowel Cancer Trial Leaves Patients Cancer-Free for Nearly 3 Years
Researchers report encouraging long-term results from an experimental treatment approach that rethinks the timing of cancer therapy. By…
Probiotics and Popular Remedies Ineffective for Irritable Bowel Syndrome, Experts Say
An American gastroenterologist introduced treatments recommended by official academic societies, stating that most irritable bowel syndrome therapies circulating…
Millions Take These IBS Drugs, But a New Study Finds Serious Risks
A large study found that some common IBS medications, including antidepressants, are associated with a slightly higher risk…
Dulaglutide, semaglutide, and tirzepatide exhibit comparable gastrointestinal adverse event risk
1. In this cohort study, dulaglutide, semaglutide, and tirzepatide demonstrated similar risks of gastrointestinal adverse events (AEs) in…